Search for stocks /

CDG Petchem Ltd Q2 FY26 – ₹0.22 Cr Sales, EPS ₹0.15, ROE -348%, Market Cap ₹71.7 Cr: When Trading Everything Still Trades Your Patience


1. At a Glance

CDG Petchem Ltd is that one BSE-listed stock which wakes up every few months, announces a new line of business, reshuffles management chairs like musical chairs at a wedding, reports microscopic revenues, and still manages to deliver 40–50% stock returns in short bursts. As of mid-December, the company sits at a market capitalisation of ₹71.7 crore with a current price of ₹77.7, having rallied over 40% in just three months. Sales over the last twelve months stand at ₹5.73 crore, while profits are still comfortably negative at ₹-0.68 crore. ROE is not just bad, it is mathematically offensive at -348%. ROCE stands at -12.4%, which basically means capital is working overtime… against shareholders. And yet, the stock is trading at 2.82x book value with zero debt and an enterprise value of ₹45.5 crore. Latest quarterly sales were just ₹0.22 crore, but quarterly PAT came in positive at ₹0.14 crore, triggering headline “profit growth” numbers that look dramatic only because the base was underground. This is a company where numbers are tiny, drama is large, and governance updates read like a Netflix political thriller. Curious already?


2. Introduction

CDG Petchem was incorporated in 2011 and, on paper, is in the business of merchant exports, third-country trade, imports, marketing, and distribution of products ranging from petrochemicals to pillows. Yes, pillows. And plastic rods. And surfactants. And construction chemicals. And pharma chemicals. Basically, if a product exists and can be invoiced, CDG Petchem has at some point claimed it can trade it.

Over the years, the company has oscillated between being a trader, a manufacturer, a distributor, and occasionally a restructuring case study. Revenues have jumped, collapsed, recovered, and then vanished again. Promoter holding has gone from over 60% to just 20.7% in 2025. Subsidiaries have been acquired and then disinvested. Safety net manufacturing units were shut down for non-viability, while new PE wax processing dreams were announced. Directors resigned in batches. New directors were appointed in batches. CFOs came, left, and were replaced—sometimes within the same financial year.

Despite all this, CDG Petchem continues to exist, trade, file results, and attract speculative attention. That alone makes it worth dissecting. Is it a misunderstood turnaround story? A shell trying to find a business? Or just a trading company trapped in permanent identity crisis? Let’s investigate, auditor-style, with raised eyebrows and a calculator.


3. Business Model – WTF Do They Even Do?

Explaining CDG Petchem’s business model is like explaining a Delhi buffet menu to someone who asked for just dal-chawal. The company primarily operates as a trading and merchant export entity. Historically, over 90% of its revenue has come from traded goods, with finished goods contributing a single-digit percentage.

The product list is aggressively diversified. Knitted fabrics, mattresses, pillows, plasticizers, minerals, plastic raw materials, shade nets, safety nets, PVC foam boards, pipes, films, EVA sheets, technical fabrics, construction chemicals, surfactants, pharma chemicals, polymer chemicals, petrochemicals, sealants—the list reads like someone copy-pasted half of an industrial expo catalogue. This tells us one thing clearly: CDG Petchem is not married to any product. It is dating the concept of trading itself.

In FY21, the company even ran a safety net manufacturing unit, which was later shut down in August 2022 due to non-viability. Management candidly admitted it was loss-making. The plan then shifted to setting up a PE wax processing unit in Vapi, Gujarat, targeting applications across plastics, paints, cosmetics, rubber processing, and candles. Whether this unit meaningfully contributes to revenue is still unclear from current numbers.

The company also had a 100% subsidiary, Morbido Merchandise Private Limited, for imports and distribution of chemicals. That subsidiary was later disinvested. So today, CDG Petchem is back to being largely a standalone trading entity with occasional manufacturing ambitions. If you’re looking for a clean, focused business model—this isn’t it. If you’re looking for flexibility and optionality—this is chaos in spreadsheet form.


4. Financials Overview

Result Type Locked: Quarterly Results
Latest EPS is quarterly. Annualised EPS = ₹0.15 × 4 = ₹0.60.

Quarterly Performance Comparison (₹ Crores)

Source table
MetricLatest Qtr (Sep 2025)YoY Qtr (Sep 2024)Prev Qtr (Jun 2025)YoY %QoQ %
Revenue0.221.100.26-80.0%-15.4%
EBITDA-0.02-0.04-0.52ImprovementImprovement
PAT0.14-0.27-0.52151.9%Turnaround
Continue reading with a premium membership.
Become a member
error: Content is protected !!